Silence Therapeutics PLC at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Good afternoon, and welcome once again to the Morgan Stanley 18th Annual Global Healthcare Conference. I'm one of the biotech analysts here. My name is David Lebowitz. Before we get going, let me just go through the requisite disclosures. Please note that this webcast is for Morgan Stanley's clients and Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'm happy to welcome into our next session from Silence Therapeutics, CFO, Rob Quinn; and CMO, Giles Campion. Silence is a development stage siRNA company, developing drugs for a wide variety of different types of diseases.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |